ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $40,049 | -30.4% | 11,955 | 0.0% | 0.00% | – |
| Q4 2022 | $57,504 | +0.9% | 11,955 | +18.5% | 0.00% | – |
| Q3 2022 | $57,000 | -20.8% | 10,090 | 0.0% | 0.00% | – |
| Q2 2022 | $72,000 | +188.0% | 10,090 | +190.9% | 0.00% | – |
| Q1 2022 | $25,000 | -19.4% | 3,469 | 0.0% | 0.00% | – |
| Q4 2021 | $31,000 | -68.4% | 3,469 | +24.4% | 0.00% | -100.0% |
| Q3 2021 | $98,000 | +4800.0% | 2,789 | +2805.2% | 0.00% | – |
| Q2 2021 | $2,000 | – | 96 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |